Emend
Product Images NDC 54868-5325

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Emend (NDC 54868-5325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (551ba90d 2152 427b 8239 872d7753fd86 01)

Chemical structure of Emend active ingredient showing a complex molecule with multiple rings including a purine-like structure and trifluoromethyl-substituted aromatic rings.*

FDA Label Image

Image Of Figure 1 (551ba90d 2152 427b 8239 872d7753fd86 02)

Two Kaplan-Meier survival-type curves labeled Study 1 and Study 2 comparing the percent of patients over time (in hours) between an Aprepitant regimen and Standard Therapy groups. The y-axis represents percent of patients, the x-axis represents hours up to 120. Each study shows higher patient percent retention with Aprepitant regimen than Standard Therapy, with sample sizes noted for each group.*

FDA Label Image

Image Of Figure 2 (551ba90d 2152 427b 8239 872d7753fd86 03)

Two bar charts labeled Study 1 and Study 2 comparing the percent of patients receiving Aprepitant Regimen versus Standard Therapy across chemotherapy cycles 2 to 6. Each chart includes patient sample sizes for each treatment group below the x-axis.*

FDA Label Image

Image Of Figure 3 (551ba90d 2152 427b 8239 872d7753fd86 04)

A line graph comparing the percentage of patients over time (in hours) treated with Aprepitant 40 mg versus Ondansetron. The x-axis represents time in hours up to 48 hours, and the y-axis shows the percent of patients from 0 to 100%. The graph includes two lines: one solid line for Aprepitant and one dashed line for Ondansetron, with sample sizes noted for each group.*

FDA Label Image

Bipack 80 mg (Package Label 01)

Label for Emend 80mg, distributed by Physicians Total Care, Inc. The label shows the lot number 0000 and expiration date 01/60. It also indicates manufacturing by Merck & Company, Inc., with a barcode and NDC 54868-5231-1.*

FDA Label Image

Tripack 125 mg And 80 mg (Package Label 02)

Label for Emend Trifold 125/80MG distributed by Physicians Total Care, Inc. in Tulsa, OK. It includes the NDC number 54868-5325-0, lot number 0000, expiration date 01/60, and states the product is manufactured by Merck & Company, Inc. in Whitehouse Station, NJ. A barcode is also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.